Oncology Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . The Oncology Institute
TOIIW Stock  USD 0.02  0.0001  0.43%   
Oncology Institute financial statements provide useful quarterly and yearly information to potential The Oncology Institute investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Oncology Institute financial statements helps investors assess Oncology Institute's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Oncology Institute's valuation are summarized below:
Gross Profit
53.7 M
Profit Margin
(0.19)
Revenue
378.9 M
Earnings Share
(602.09)
Quarterly Revenue Growth
0.218
There are over one hundred nineteen available trending fundamental ratios for The Oncology Institute, which can be analyzed over time and compared to other ratios. All traders should should check out Oncology Institute's recent fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Enterprise Value is likely to climb to about 494.9 M in 2025, whereas Market Cap is likely to drop slightly above 164.4 M in 2025.

Oncology Institute Total Revenue

226.56 Million

Check Oncology Institute financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncology Institute's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.8 M, Interest Expense of 8.2 M or Selling General Administrative of 67.6 M, as well as many indicators such as Price To Sales Ratio of 0.51, Dividend Yield of 0.0235 or PTB Ratio of 2.88. Oncology financial statements analysis is a perfect complement when working with Oncology Institute Valuation or Volatility modules.
  
Check out the analysis of Oncology Institute Correlation against competitors.
For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

Oncology Institute Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding68.4 M84.8 M47.3 M
Slightly volatile
Total Assets176.4 M240.6 M109.6 M
Slightly volatile
Other Current Liabilities11.2 M15.5 M7.5 M
Slightly volatile
Total Current Liabilities30.1 M40 M20.6 M
Slightly volatile
Total Stockholder Equity78.4 M65.6 M55 M
Slightly volatile
Property Plant And Equipment Net48.4 M46.1 M11.8 M
Slightly volatile
Accounts Payable13.4 M16.6 M10.7 M
Slightly volatile
Cash37.5 M38.5 M16.8 M
Slightly volatile
Non Current Assets Total70.9 M75.6 M50.5 M
Slightly volatile
Non Currrent Assets Other323.5 K645.1 K207.5 K
Slightly volatile
Cash And Short Term Investments61.5 M95.3 M28.6 M
Slightly volatile
Net Receivables30 M49.3 M21.8 M
Slightly volatile
Good Will6.2 M6.5 M14.1 M
Pretty Stable
Liabilities And Stockholders Equity176.4 M240.6 M109.6 M
Slightly volatile
Non Current Liabilities Total67.9 M135 M34.1 M
Slightly volatile
Inventory8.3 M15.7 M6 M
Slightly volatile
Other Current Assets5.7 M4.7 M2.7 M
Slightly volatile
Other Stockholder Equity140.2 M233.6 M63.2 M
Slightly volatile
Total Liabilities98 M175 M54.6 M
Slightly volatile
Property Plant And Equipment Gross55.8 M53.2 M13.5 M
Slightly volatile
Total Current Assets105.5 M165 M59.1 M
Slightly volatile
Capital Stock6.8 K7.2 K35.1 M
Slightly volatile
Non Current Liabilities Other312.1 K328.5 K1.1 M
Pretty Stable
Net Working Capital75.5 M125 M38.6 M
Slightly volatile
Intangible Assets15.3 M16.1 M20.3 M
Slightly volatile
Common Stock6.3 K9.2 K3.1 K
Slightly volatile
Short and Long Term Debt Total144.5 M137.6 M40.1 M
Slightly volatile
Current Deferred Revenue466 K490.5 K2.5 M
Slightly volatile
Long Term Debt63.8 M99.8 M30.2 M
Slightly volatile
Short and Long Term Debt156.5 K164.7 K3.7 M
Slightly volatile
Short Term Debt4.8 M7.3 M5.2 M
Very volatile

Oncology Institute Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.8 M6.8 M2.5 M
Slightly volatile
Interest Expense8.2 M7.8 M1.7 M
Slightly volatile
Selling General Administrative67.6 M132.6 M45.8 M
Slightly volatile
Total Revenue226.6 M372.9 M171.3 M
Slightly volatile
Gross Profit45 M68.5 M35.6 M
Slightly volatile
Other Operating Expenses263.4 M461.4 M189.3 M
Slightly volatile
Cost Of Revenue181.5 M304.4 M135.7 M
Slightly volatile
Total Operating Expenses81.9 M157.1 M53.6 M
Slightly volatile
Reconciled Depreciation3.8 M6.3 M2.5 M
Slightly volatile
Selling And Marketing Expenses33.3 M37.4 M40.8 M
Slightly volatile

Oncology Institute Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow25.2 M16.1 M11.2 M
Slightly volatile
Depreciation3.8 M6.8 M2.5 M
Slightly volatile
Capital Expenditures3 M5.3 M1.9 M
Slightly volatile
End Period Cash Flow31.4 M38.5 M15.1 M
Slightly volatile
Stock Based Compensation15.5 M20.5 M6.7 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.510.532.173
Slightly volatile
Dividend Yield0.02350.02650.0289
Slightly volatile
PTB Ratio2.883.0311.6555
Slightly volatile
Days Sales Outstanding34.143.4737.6366
Slightly volatile
Book Value Per Share0.830.70.7885
Slightly volatile
Average Payables8.6 M9.7 M10.6 M
Slightly volatile
Stock Based Compensation To Revenue0.04590.04940.0242
Slightly volatile
Capex To Depreciation0.580.70.6681
Pretty Stable
PB Ratio2.883.0311.6555
Slightly volatile
EV To Sales0.80.843.0839
Slightly volatile
Inventory Turnover29.2722.2529.6816
Slightly volatile
Days Of Inventory On Hand11.5416.9812.652
Slightly volatile
Payables Turnover12.1916.5114.4977
Pretty Stable
Sales General And Administrative To Revenue0.00130.00150.0016
Slightly volatile
Capex To Revenue0.00950.01270.0089
Slightly volatile
Cash Per Share0.641.010.3746
Slightly volatile
Payout Ratio1.661.872.0381
Slightly volatile
Days Payables Outstanding28.2722.8825.7669
Very volatile
Intangibles To Total Assets0.130.140.4589
Slightly volatile
Current Ratio2.613.712.3167
Slightly volatile
Receivables Turnover9.858.699.8895
Slightly volatile
Shareholders Equity Per Share0.830.70.7885
Slightly volatile
Debt To Equity1.981.890.7192
Slightly volatile
Capex Per Share0.0330.05570.0331
Slightly volatile
Average Receivables12.8 M14.4 M15.7 M
Slightly volatile
Revenue Per Share2.733.963.6642
Slightly volatile
Interest Debt Per Share1.621.540.4145
Slightly volatile
Debt To Assets0.540.510.2519
Slightly volatile
Graham Number0.750.840.9189
Slightly volatile
Operating Cycle45.6460.4550.2886
Slightly volatile
Price Book Value Ratio2.883.0311.6555
Slightly volatile
Days Of Payables Outstanding28.2722.8825.7669
Very volatile
Dividend Payout Ratio1.661.872.0381
Slightly volatile
Company Equity Multiplier1.843.31.832
Slightly volatile
Long Term Debt To Capitalization0.320.540.2707
Slightly volatile
Total Debt To Capitalization0.640.610.3545
Slightly volatile
Debt Equity Ratio1.981.890.7192
Slightly volatile
Quick Ratio2.393.362.0351
Slightly volatile
Net Income Per E B T1.121.150.9302
Slightly volatile
Cash Ratio0.90.870.5655
Slightly volatile
Cash Conversion Cycle25.0842.5425.3142
Slightly volatile
Days Of Inventory Outstanding11.5416.9812.652
Slightly volatile
Days Of Sales Outstanding34.143.4737.6366
Slightly volatile
Price To Book Ratio2.883.0311.6555
Slightly volatile
Fixed Asset Turnover8.849.3173.3411
Slightly volatile
Debt Ratio0.540.510.2519
Slightly volatile
Price Sales Ratio0.510.532.173
Slightly volatile
Asset Turnover1.971.782.2637
Slightly volatile
Gross Profit Margin0.220.210.2188
Slightly volatile
Price Fair Value2.883.0311.6555
Slightly volatile

Oncology Institute Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap164.4 M173 M509 M
Slightly volatile
Enterprise Value494.9 M272.1 M538.8 M
Slightly volatile

Oncology Fundamental Market Drivers

Cash And Short Term Investments82.9 M

About Oncology Institute Financial Statements

Oncology Institute investors use historical fundamental indicators, such as Oncology Institute's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Oncology Institute. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue490.5 K466 K
Total Revenue372.9 M226.6 M
Cost Of Revenue304.4 M181.5 M
Stock Based Compensation To Revenue 0.05  0.05 
Capex To Revenue 0.01  0.01 
Revenue Per Share 3.96  2.73 
Ebit Per Revenue(0.27)(0.29)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Oncology Stock Analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY